Forest Investigative Site 292 — Dawsonville, Georgia

Forest Investigative Site 292 is a clinical research site located in Dawsonville, Georgia, United States 30534.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Forest Investigative Site 292 has participated in 1 clinical trials.

Therapeutic areas: COPD, COPD Exacerbation, Lung Diseases.

Sponsors: AstraZeneca.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 292?

Forest Investigative Site 292 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 292 conducted?

Forest Investigative Site 292 has 1 clinical trials on record. Their work covers COPD, COPD Exacerbation, Lung Diseases.

Is Forest Investigative Site 292 accredited by Crixeo Health?

Forest Investigative Site 292 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 292?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.